South Shore's First Medical Marijuana Dispensary Opens To The Public
Hanover Facility Offers Premium Strains Including Bootlegger, Chupacabra, Iron Triangle and Slazerbeam
HANOVER, MA - October 23, 2017 (Investorideas.com Newswire) Curaleaf, formerly known as Mass Organic Therapy, today celebrated the public opening of the first medical marijuana dispensary on Boston's South Shore. The dispensary is conveniently located off of Route 3 at 2001 Washington Street in Hanover and serves the South Shore and Cape areas.
"Today marks an important milestone for South Shore patients that are suffering and in need of medicinal cannabis," said Nichole Snow, the Executive Director of the Massachusetts Patient Advisory Alliance. "For far too long, they had limited access to this important treatment option, but now the wait is over."
"We are proud to finally open this dispensary, better serve patients on the South Shore and meet the high standards of Massachusetts' medical marijuana program," said Patrik Jonsson, CEO of Curaleaf MA. "We chose the location to ensure convenience and accessibility for patients, and we look forward to helping patient treatment with our medical-grade cannabis."
At Curaleaf, patients have access to a large selection of pharmaceutical-grade medical marijuana products that include flower, edibles, concentrates and vaporizer cartridges. The company offers 13 strains, including its premium Bootlegger, Chupacabra, Iron Triangle and Slazerbeam varieties.
Curaleaf specialized consultants work with each patient to determine the product that best fits their needs. Patients experience a bright, warm and welcoming environment and spa-like atmosphere at the Hanover location.
Curaleaf is dedicated to delivering an exceptional patient and caregiver experience to all cannabis patients, regardless of their economic status. Low-income patients can qualify for Curaleaf's Compassionate Care Program, and veteran discounts are always available.
The dispensary will be open seven days a week 9 AM – 7 PM Monday through Saturday and 10 AM – 2 PM on Sunday. New patients will receive a discount of 25% off all medical products.
For those outside of the South Shore and Cape areas, Curaleaf plans to open locations in Oxford and Provincetown in early 2018.
Visit Curaleaf at 2001 Washington Street, Unit B, Hanover, MA 02339 (located in the back of the building), or online at www.Curaleaf.com. And see our pages on Facebook, Twitter and Instagram at @MACuraleaf. To contact us directly, call Curaleaf by phone at (781) 987-1646.
Led by a team of physicians, pharmacists, medical experts and industry visionaries, Curaleaf develops safe, effective, and innovative cannabis-based therapeutic products. Curaleaf combines the industry's most medically precise and technologically advanced production techniques with decades of horticultural experience, to ensure consistently exceptional quality that patients and health care professionals can trust. Based on a foundation of compassion, professionalism and respect, Curaleaf strives to empower physicians and patients by helping them make the right choices, as the industry's leading resource in product expertise, education, and through their commitment to advancement through research and advocacy. More information regarding Curaleaf can be found at www.curaleaf.com.
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.